Y 700 - PiraxostatNiraxostat, 10 mM in DMSOAETHRPHBGJAIBT-UHFFFAOYSA-N1H-PYRAZOLE-4-CARBOXYLIC ACID, 1-[3-CYANO-4-(2,2-DIMETHYLPROPOXY)PHENYL]-
Y 7001-[3-cyano-4-(2,2-dimethylpropoxy)phenyl]pyrazole-4-carboxylic acid1-[3-CYANO-4-(NEOPENTYLOXY)PHENYL]-1H-PYRAZOLE-4-CARBOXYLIC ACID1-[3-Cyano-4-(2,2-dimethyl-propoxy)-phenyl]-1H-pyrazole-4-carboxylic acidCHEMBL1695261-(3-cyano-4-neopentyloxyphenyl) pyrazole-4-carboxylic acid1-(3-Cyano-4-(neopentyloxy)phenyl)-1H-pyrazole-4-carboxylic acidUNII-246FR6022S
Database identifiers
CAS
206884-98-2
PubChem CID
449035
DTXSID
DTXSID70174747
ChEMBL
CHEMBL169526
UNII
246FR6022S
Nikkaji
J1.490.905B
Properties
Computed structural properties
XLogP
2.8
Topological polar surface area
88.1 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
5
Heavy atoms
22
Formal charge
0
Complexity
451
Experimental & physicochemical properties
DrugsPharmaceuticals -> Listed in ZINC15
Physicochemical properties
Boiling point
500.5 · 500.5±45.0 °C(Predicted)
Density
1.2 · 1.20±0.1 g/cm3(Predicted)
pka
3.68 · 3.68±0.10(Predicted)
form
Solid
color
White to off-white
FDA UNII
246 FR6022S · 246FR6022S
Chemistry & industry
Applications
UsesNiraxostat (Y-700; Piraxostat) is an orally active xanthine oxidoreductase (XOR) inhibitor used in the study of hyperuricemia and other diseases in which XOR may be involved[1].